Funds will be used to perform genetic sequencing on DNA of populations with bipolar disorder from Africa, Central America, South America and Asia and study brain tissue from people who lived with the disorder, according to a March 30 news release from the organization.
“The discoveries from this research will over time enable long-sought advances in clinical care,” Eric Nestler, MD, PhD, chair of the scientific steering committee overseeing Breakthrough Discoveries, said in the release.
